PM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the ...

Caris Life Sciences has filed to raise $100 million in a U.S. IPO, although the final amount may be higher. Click here to read more about CAI stock and the IPO.